Benefits of treating impaired sleep in OIF/OEF Veterans with TBI and PTSD Robert L. Ruff, MD, PhD Suzanne S. Ruff, PhD Cleveland Dept of Veterans Affairs.

Slides:



Advertisements
Similar presentations
Mild TBI and Persisting PCS (Post Concussion Syndrome) Mary Pepping, Ph.D. Dept. of Rehabilitation Medicine University of Washington School of Medicine.
Advertisements

This article and any supplementary material should be cited as follows: Spencer RJ, McGuire AP, Tree HA, Waldron-Perrine B, Pangilinan PH, Bieliauskas.
Botulinum toxin type A for the prevention of headaches in adults with chronic migraine.
EPECEPECEPECEPEC EPECEPECEPECEPEC Depression, Anxiety, Delirium Depression, Anxiety, Delirium Module 6 The Project to Educate Physicians on End-of-life.
What is it? -FM is the inflammation of white fibrous tissues (especially muscle sheaths). - FM is one of the main causes of Chronic Widespread Pain (CWP).
Describe and Evaluate the Cognitive Treatment for Schizophrenia
Smoking Cessation in Smokers Motivated to Quit Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Robert Anthenelli.
A Clinician's Approach to Fatigue of Cancer Patients
Rodney D. Vanderploeg, Ph.D., ABPP-CN
MILD TRAUMATIC BRAIN INJURY AND POST TRAUMATIC STRESS DISORDER (Theater) Battlemind Training System Office U.S. Army Medical Department Center and School.
The European Network for Traumatic Stress Training & Practice
RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Chronic Pain Syndromes.
The Role of Clinical Pharmacists in Outpatient Psychiatric Clinics Mary A. Gutierrez, Pharm.D., BCPP Associate Professor of Clinical Pharmacy University.
Rehabilitation Counseling and Cognitive Therapy
Department of Veterans Affairs
Inpatient program Mild TBI / Post-deployment stress Evaluations Treatment Multi- and Inter-disciplinary Post-deployment Rehabilitation & Evaluation Program.
1 Trauma Systems Therapy for Adolescent Substance Abuse (TST-SA) Liza Suárez, Ph.D. Glenn Saxe, MD Center for Anxiety and Related Disorders Center for.
Experts in PTSD Oto Gordon Psy 496 January 29, 2015.
Basics of outpatient depression management Chris Zamani MD.
Curative early psychosocial interventions: evidence-based! Dr Jonathan I Bisson Clinical Reader in Psychiatry Cardiff University.
Ardiana Murtezani MD, PhD 1, 2, Nerimane Abazi MD 1,2, Zana Ibraimi PHARM PhD 2,Fatime Haxholli MD 1,2, Zana Agani DDS PhD 2,3, Elena Kamberi DDS 2.
Psyc 190: Warriors At Home Traumatic Brain Injury, Depression & Anger Dr. Elena Klaw.
FIVE MINUTES TO MAKE A DIFFERENCE Presentation by: Mark Barnes.
Switch NNRTI to NNRTI  Switch EFV to ETR –CNS toxicity study –Patient’s preference study.
Extended duration of injection interval. 2 Lucas et al. Efficacy of lanreotide Autogel ® administered every 4–8 weeks in patients with acromegaly previously.
 Overview for this evening Seminar!  Anxiety Disorders (PTSD) and Acute Stress  Treatment planning for PTSD  Therapy methods for PTSD and Acute Stress.
Washington D.C., USA, July 2012www.aids2012.org Collaborative HIV/AIDS Mental Health Project (CHAMP) Susan Reif, PhD, LCSW Center for Health Policy.
PATIENT CASE Module 4 Date of preparation: June 2015 HQ/EFF/15/0024h.
Anticonvulsant Therapy for Traumatic Brain Injury
C-BR- 1 Raptiva ™ (efalizumab) Benefit:Risk Assessment Charles Johnson, MB, ChB Senior Director Head of Specialty Biotherapeutics Genentech, Inc.
Introduction The use of analgesics, sedatives, and paralytic agents are an important tool to help decrease pain and anxiety while improving the quality.
Detecting and Diagnosing PTSD in Primary Care Joseph Sego Advisor Dr. Grimes.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Prazosin (and Other Medications) for PTSD and mTBI Murray A. Raskind, MD Director, VISN-20 Mental Illness Research, Education, and Clinical Center Professor.
This article and any supplementary material should be cited as follows: Oleksiak M, Smith BM, St. Andre JR, Caughlan CM, Steiner M. Audiological issues.
This article and any supplementary material should be cited as follows: Van Voorhees BW, Gollan J, Fogel J. Pilot study of Internet-based early intervention.
بسم الله الرحمن الرحيم Dr: Samah Gaafar Hassan Al-shaygi.
Principles of Effective Drug Addiction Treatment Health 10 The Truth About Drugs Ms. Meade.
What the National Institute on Drug Abuse’s Clinical Trials Network Can Do for You? Major Findings from Medication Trials and Implications for Community-Based.
Cognitive Deficits as a Treatment Moderator? Jennifer J. Vasterling, Ph.D. VA Boston Healthcare System VA National Center for PTSD P3+ Research Summit.
LO: To be able to describe and evaluate the Cognitive Treatment for Schizophrenia.
Long-Term Tolerability of Ticagrelor for Secondary Prevention: Insights from PEGASUS-TIMI 54 Trial Marc P. Bonaca, MD, MPH on behalf of the PEGASUS-TIMI.
Randomized Controlled CTN Trial of OROS-MPH + CBT in Adolescents with ADHD and Substance Use Disorders Paula Riggs, M.D., Theresa Winhusen, PhD., Jeff.
Prednisone Uses Stress Prednisone Cost foods to avoid on prednisone dealing with prednisone mood swings oral prednisone dosage for poison oak can prednisone.
Non-pharmacological interventions to reduce psychological sequelae of mild traumatic brain injury: A systematic review Dr Nikola Creasey Paediatric Emergency.
NICE guidance Generalised Anxiety Disorder Alex Hill.
Date of download: 9/20/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of a Palliative Care Intervention on Clinical.
Disability After Traumatic Brain Injury among Hispanic Children
Person centred research
The Combination of Tai Chi, Cognitive Behavioral Therapy and Motivational Text Messaging Improves Physical Function, Reduces Substance Use and Improves.
Post-deployment Rehabilitation & Evaluation Program -PREP-
Robert L. Ruff, M. D. , Ph. D. 1,3 Suzanne Ruff, Ph. D
Psychoeducational group therapy within a pediatric residency clinic:
ACUPUNCTURE A TREATMENT FOR PAINFUL DIABETIC NEUROPATHY
Ferhat Yaylacı, Handan Özek Erkuran, Murat Eyüboğlu***
Sleep and Adhd The Link between Parent and Child Sleep Disturbances in Children with Attention Deficit Hyperactivity Disorder Dr. Martin Efron The Child.
Fatigue Management Program
Primary Care Challenges in Depression - To Treat or Refer?
PTSD Lecturer TBD.
Clinical Trial Results with OROS® Hydromorphone
Session Title: Dementia-Breaking The Barriers Speaker Name: Nasseer Masoodi, MD, MBA, FACP Assistant Chair/Senior Consultant; Ambulatory General Internal.
Post-Acute Rehabilitation Length of Stay and Traumatic Brain Injury Outcome Jessica Ashley, Ph.D. 42nd Traumatic Brain Injury Rehabilitation Conference.
Describe and Evaluate the Cognitive Treatment for Schizophrenia
The adequacy of the minimum data set assessment of pain in cognitively impaired nursing home residents  Jiska Cohen-Mansfield, PhD, ABPP  Journal of Pain.
Use of the Cumulative Proportion of Responders Analysis Graph to Present Pain Data Over a Range of Cut-Off Points: Making Clinical Trial Data More Understandable 
FX006 Pivotal Ph 2b Data September , 2015
Critical Decision Points in Insomnia
Essentials of Good Pain Care: A Team-Based Approach
Use arrow keys to move forward or backward through presentation
Interreg-IPA Cross-border Cooperation Programme Romania-Serbia
Presentation transcript:

Benefits of treating impaired sleep in OIF/OEF Veterans with TBI and PTSD Robert L. Ruff, MD, PhD Suzanne S. Ruff, PhD Cleveland Dept of Veterans Affairs Medical Center Cleveland OH 44106

To consider how treatment can be adapted to the needs of the OIF/OEF veterans To consider how treatment can be adapted to the needs of the OIF/OEF veterans To consider treating sleep along with PTSD as initial step for veterans with mild TBI associated with exposure to explosions To consider treating sleep along with PTSD as initial step for veterans with mild TBI associated with exposure to explosions ObjectivesObjectives

How do you deal with the complex of mTBI, PTSD and impaired sleep? Have to develop a Rx strategy that vets will accept, that may improve their likelihood of responding to other Rx and that enables them to function in society. Have to develop a Rx strategy that vets will accept, that may improve their likelihood of responding to other Rx and that enables them to function in society. We addressed impaired sleep first We addressed impaired sleep first Dr. Murray Raskind found Prazosin to be very effective in improving sleep of veterans with PTSD. Blocks nightmares without disrupting REM or the transition of REM to stage 3 Dr. Murray Raskind found Prazosin to be very effective in improving sleep of veterans with PTSD. Blocks nightmares without disrupting REM or the transition of REM to stage 3

Prazosin/Sleep Hygiene Study Study group – 74 OIF/OEF veterans who had neurocognitive deficits and headaches Study group – 74 OIF/OEF veterans who had neurocognitive deficits and headaches All had baseline MOCA and Epworth Sleepiness Scale scores and headache intensity and frequency. All had baseline MOCA and Epworth Sleepiness Scale scores and headache intensity and frequency. All were given sleep hygiene counseling and started on an upward taper of prazosin from 1mg qHS to 7 mg qHS All were given sleep hygiene counseling and started on an upward taper of prazosin from 1mg qHS to 7 mg qHS Assessments – baseline, 9 weeks later, 9 weeks + 6 months later Assessments – baseline, 9 weeks later, 9 weeks + 6 months later

Hypotheses 1) OIF/OEF veterans would tolerate prazosin with a low incidence of side effects 2) prazosin combined with sleep hygiene counseling would improve sleep among OIF/OEF veterans with mTBI 3) veterans who took prazosin and received sleep hygiene counseling would have less severe headache pain and fewer headaches.

Performance of veterans at baseline and after intervention ESS Scores (0-24) MOCA Score (0-30) Headache Pain Intensity (0-10) Headache Frequency (#/month) Completed Prazosin Baseline (N = 62) After intervention p< p< p< p<0.001 Did not complete Baseline (N=12) After intervention p< p-NS p-NS p-NS Prazosin/Sleep Hygiene Improved Performance

Prazosin Compliance – 6 months 64/74 (86%) taking prazosin 64/74 (86%) taking prazosin 26 of the veterans received additional medication for their headaches 26 of the veterans received additional medication for their headaches 22 veterans - changes in the PTSD medication (dosing or drug) 22 veterans - changes in the PTSD medication (dosing or drug)

Performance of veterans ESS Scores (0-24) MOCA Score (0-30) Headache Pain Intensity (0-10) Headache Frequency (#/month) Took Prazosin (60) Baseline Baseline End of 9 week End of 9 week End of 6 month End of 6 month A, B, C A, B A, B, C A, B, C No Prazosin (8) Baseline Baseline End of 9 week End of 9 week End of 6 month End of 6 month A, B A baseline vs. 9 week - significant at the 0.05 level B baseline vs. 6 months level C 9 week vs. 6 months level

Conclusions: Prazosin/Sleep Hygiene Well tolerated Well tolerated Reduced headache frequency and pain intensity and was associated with improved cognitive performance Reduced headache frequency and pain intensity and was associated with improved cognitive performance Improving sleep may be able to break the triad of mTBI-PTSD-Pain (Kerns-P3) Improving sleep may be able to break the triad of mTBI-PTSD-Pain (Kerns-P3) Rod Vanderploeg – impaired sleep may be critical in prolonged post-mTBI symptoms Rod Vanderploeg – impaired sleep may be critical in prolonged post-mTBI symptoms

Thank You Robert L. Ruff, MD, PhD Suzanne S. Ruff, PhD Cleveland Dept of Veterans Affairs Medical Center Cleveland OH ext 5230 (Robert) 4486 (Suzanne)